The Future of Chimeric Antigen Receptor T Cell Therapy. Hematol Oncol Clin North Am. 2023 Jul 11.
View in:
PubMed
CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience. J Immunother Cancer. 2022 02; 10(2).
View in:
PubMed
Chimeric Antigen Receptor-Modified Immune Effector Cell Therapies: Learning From the Present; Charting a Path to the Future. Cancer J. 2021 Mar-Apr 01; 27(2):90-91.
View in:
PubMed
Multiple Myeloma, Targeting B-Cell Maturation Antigen With Chimeric Antigen Receptor T-Cells. Cancer J. 2019 May/Jun; 25(3):208-216.
View in:
PubMed
Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies. Int J Hematol. 2014 Apr; 99(4):361-71.
View in:
PubMed